"Sarcoglycans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of transmembrane dystrophin-associated proteins that play a role in the membrane association of the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX.
| Descriptor ID |
D049031
|
| MeSH Number(s) |
D12.776.210.500.410.750 D12.776.543.268.750 D12.776.543.550.712
|
| Concept/Terms |
beta-Sarcoglycan- beta-Sarcoglycan
- beta Sarcoglycan
- 43-kDa Dystrophin-Associated Glycoprotein
- 43 kDa Dystrophin Associated Glycoprotein
- Dystrophin-Associated Glycoprotein, 43-kDa
- Glycoprotein, 43-kDa Dystrophin-Associated
alpha-Sarcoglycan- alpha-Sarcoglycan
- alpha Sarcoglycan
- Adhalin
- 50-kDa Dystrophin-Associated glycoprotein
- 50 kDa Dystrophin Associated glycoprotein
- Dystrophin-Associated glycoprotein, 50-kDa
- glycoprotein, 50-kDa Dystrophin-Associated
|
Below are MeSH descriptors whose meaning is more general than "Sarcoglycans".
Below are MeSH descriptors whose meaning is more specific than "Sarcoglycans".
This graph shows the total number of publications written about "Sarcoglycans" by people in this website by year, and whether "Sarcoglycans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoglycans" by people in Profiles.
-
P38a MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism. Hum Mol Genet. 2014 Oct 15; 23(20):5452-63.
-
miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol. 2011 Jun 27; 193(7):1197-212.
-
Maternal uniparental disomy of chromosome 4 in a patient with limb-girdle muscular dystrophy 2E confirmed by SNP array technology. Clin Genet. 2012 Jun; 81(6):578-83.
-
Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D. Ann Neurol. 2010 Nov; 68(5):629-38.
-
SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum Mol Genet. 2007 Feb 01; 16(3):327-42.
-
Examination of the SGCE gene in Tourette syndrome patients with obsessive-compulsive disorder. Mov Disord. 2004 Oct; 19(10):1237-8.
-
Proteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteins. Am J Pathol. 2003 Oct; 163(4):1663-75.
-
Altered muscle force and stiffness of skeletal muscles in alpha-sarcoglycan-deficient mice. Am J Physiol Cell Physiol. 2003 Apr; 284(4):C962-8.
-
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem. 2002 Oct 11; 277(41):38988-97.
-
Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol Cell Biol. 2000 May; 20(9):3308-15.